Getting Started
Authors need to submit their manuscripts through the online submission platform available at https://editorialassist.com/ijdvl. Articles submitted as hard copies are not accepted. All manuscripts received online are automatically acknowledged by e-mail which mentions tracking article number for future reference. Do not send articles by e-mail or post. The progress of a manuscript through the editorial process can be subsequently tracked by authors on the submission platform. Do not send any material to the Editorial office. We have a policy of accepting submissions of articles, the pre-reviewed versions of which have been archived on pre-print servers, provided these have not been cited prior to submission.
Types of Manuscripts
Indian Journal of Dermatology, Venereology and Leprology publish manuscripts in the following categories:
Please do not submit any article in the categories of editorials/book reviews/obituaries as these are only open to invited authors. Any articles submitted under these categories shall be rejected.
- Editorial
- Original Article
- Epidemiological studies
- Basic science studies
- Review Article
- Award Article
- Brief Reports
- Commentary
- Images in Dermatology
- Letters to the Editor
- Failure is instructive: mistakes made, lessons learnt
- History
- Residents’ page
- Focus
- Viewpoint
- Quiz
- Net Section
- Net Images
- Net Study
- Net Letter
- Announcements
- Book Review
- Supplements
- Pearls/Tips and tricks
- Musings
- Snippets
- Systematic Reviews and Meta-analysis
General Information
Indian Journal of Dermatology, Venereology and Leprology (IJDVL) publishes original works and findings that contribute to the advancements in the field of Clinical and Experimental Dermatology, Cutaneous Biology, Dermatological Therapeutics, Cosmetic Dermatology, Dermatopathology, Dermatosurgery, Pediatric Dermatology, Photodermatology, HIV Medicine.
Author Responsibility
The journal accepts only original work that has not been published elsewhere. All authors must confirm that neither the manuscript nor any part of it was written or published or is under consideration for publication elsewhere. Publication of the content as an abstract during the proceedings of meetings is not considered prior publication and can be submitted for publication. At the time of submission, authors should disclose details, if the study described in the manuscript had been previously presented in a meeting or published as an abstract. The details have to be mentioned in the Acknowledgments section. Any use of previously published material protected by copyright laws must be clearly acknowledged in the manuscript. Publishing of material on a website may be considered prior to publication and should be mentioned at the time of submission. Authors should disclose details of related papers even those authored in a different language.
After the manuscript is accepted, it is not possible to add/remove/modify the name of any author.
Authorship credit should be based only on substantial contributions to any of the four components mentioned below:
- Concept and design of the study, acquisition of data, or analysis and interpretation of data;
- Drafting the article or revising it critically for important intellectual content;
- Final approval of the version to be published; and
- Aptitude to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Each contributor should have participated sufficiently in the work to take public responsibility for the appropriate content of the manuscript. The order of naming the contributors should be based on the relative contribution of the individual included for authorship credit toward the study itself and the writing of the manuscript. Once the article has been submitted, the order cannot be changed without written consent from all the contributors.
The authors need to identify one author who will correspond with the Journal office in all matters related to the manuscript called the Corresponding Author. The content of the final manuscript including changes suggested by the Editor or reviewer of the manuscript is the responsibility of the corresponding author.
Ethics
Studies conducted must adhere to and be in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. According to (Federal Research Misconduct Policy) scientific misconduct includes:
- Data falsification: Fabrication, deceptive and selective reporting of findings, suppression of data and/or distortion of data
- Plagiarism: Use without permission the language, ideas, or thoughts of another and representation of them as one’s own original work
Direct copying of sentences, whether from their previously published paper or from someone else’s paper, is considered plagiarism. Authors need to check that they have not inadvertently ‘cut and paste’ verbatim from published works.
Clinical Trials Registry
It is mandatory that all the prospective clinical trial involving humans should be registered with the National (e.g. CTRI for India – details available at https://ctri.nic.in/Clinicaltrials/login.php) / Regional trial registry. The registration ID number is to be provided at the time of manuscript submission.
Plagiarism
According to the World Association of Medical Editors Plagiarism is the use of other’s published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism are to mislead the reader as to the contributions of the plagiarizer. This applies to whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format (print or electronic).
Self-plagiarism refers to the practice of an author using portions of their previous writings on the same topic in another of their publications, without specifically citing it formally in quotes. This practice is widespread and sometimes unintentional. The journal requires authors to disclose information and cite references about reused content from previously published work of their own or of others.
Incorrect authorship: Excluding authors, wrongly presenting the same material as original in more than one publication, the inclusion of authors who have not made a definite contribution to the work published; or submission of articles without the concurrence of all authors.
Misappropriation of the ideas of others: an important aspect of scholarly activity is the exchange of ideas among colleagues. Scholars can acquire novel ideas from others during the process of reviewing grant applications and manuscripts. However, improper use of such information can constitute fraud. Wholesale appropriation of such material constitutes misconduct.
Violation of generally accepted research practices: Improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results.
Material failure to comply with legislative and regulatory requirements affecting research: Violations of regulations and laws involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biological, or chemical materials.
Any form of unethical behavior is strictly discouraged and will result in the submitting author and his group being banned from submitting material to the journal for a time frame depending on the severity of malpractice.
Digital Image Editing Ethics
No particular feature within an image may be introduced, moved, enhanced, obscured, or removed. Adjustments of brightness, contrast, colour balance or image background are allowed if they are applied to the whole image and do not obscure or eliminate any information present in the original image. Adjustments such as changes to settings must be disclosed in the figure legend.
Contribution Details
The authors should provide a description of contributions made by each of them toward the manuscript. The description should be divided into the following categories, as deemed applicable: concept, design, the definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing, and manuscript review. One or more authors should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as ‘guarantor’ or ‘guarantors’.
Conflicts of Interest/Competing Interests
All authors must disclose any and all conflicts of interest they may have with the publication of the manuscript or any institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose any conflict of interest with products that compete with those mentioned in their manuscript.
Institutional Review Board/Ethics Committee Approval and Informed Consent
All prospective and retrospective human studies must have appropriate institutional review board approval, and signed informed consent from all human participants is required. All animal studies must have an appropriate institutional review board or animal care committee or institutional ethics committee approval.
Compliance with these rules must be stated in the text, including a waiver of consent by the board, if applicable. Manuscripts that do not comply with these rules will not be accepted for publication.
Patient consent and or Ethical approval statements along with Protocol number and date must be included in all research articles.
Protection of Patients’ Right to Privacy
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.
Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, CT scans, photographs, sonograms, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.
Reporting Guidelines
Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement.
Reporting Guidelines for Specific manuscript types are given below. A statement of compliance with the appropriate guideline must be included on the title page of the manuscript.
The Editorial Process
Indian Journal of Dermatology, Venereology and Leprology has a highly rigorous double-blind peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel, and meaningful.
Manuscripts are subjected to an unbiased double-blinded peer-review process. Decisions on accepting manuscripts for publication are solely based on the peer-review process, and the Editor’s discretion and decision are final. The manuscript is sent for peer review to at least two external reviewers, and if required, it is sent to a third reviewer to act as a tie-breaker. A completed review by two reviewers recommending the acceptance of the manuscript for publication is mandatory.
Manuscripts submitted for publication in the Indian Journal of Dermatology, Venereology and Leprology are sent for blind review. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. The comments and suggestions (acceptance/rejection/amendments to the manuscript) received from reviewers are conveyed to the author. The author is requested to provide a point-by-point response to reviewers’ comments and submit a revised manuscript version. This process is repeated until reviewers and editors are satisfied with the manuscript.
Manuscripts accepted for publication are copy-edited for grammar, punctuation, print style, and format. Galley proofs are sent to the author. The author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The process of submitting the manuscript to the final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online immediately on final acceptance.
Manuscripts that do not conform to the Author Guidelines or exceed the Maximums set for Articles may be returned to the author without review. Authors can resubmit after complying with the requirements.
In-house submissions
In-house submissions that contain the work of any editorial board member are not allowed to be reviewed by that editorial board member, and an independent editor makes all decisions regarding this manuscript. In addition, these manuscripts are reviewed by two external reviewers. This is also disclosed in the published manuscript under the section of Conflict of Interest.
Data Sharing Policy
NIH funded researchers, please follow the NIH guidelines on Data sharing as given at: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-013.html
Preparation of the Manuscript
The manuscript should be double-spaced, with a 2.5 cm margin, 12-point Times New Roman font and justified. The pages of the manuscript should be numbered on the bottom right corner.
Language and Writing Style
The manuscript should be written in British English. The author should write the full term for each abbreviation at its first use in the title, abstract, keywords and text separately unless the abbreviation is a standard unit of measure. The use of acronyms and abbreviations must be kept to a minimum. When used, they are defined at first mention, followed by the acronym or abbreviation in parentheses. If a brand name is cited, supply the manufacturer’s name and address (city, state, and country). Manuscripts will be altered to meet the style guidelines of the Indian Journal of Dermatology, Venereology and Leprology. The authors are requested to check the manuscript for spelling, grammar, and punctuation errors before submission. Headings and titles must be in sentence case and not in Capitals.
Organization of Sections in an Article
Cover Page
This document should carry the title of the article, a short running title, a covering letter, the names of all contributors and their professional affiliations; the name, address, phone numbers and email address of the corresponding contributor, word count, table and figure counts, acknowledgment(s) if any and an author contribution table.
Title- Title should be complete encompassing all relevant aspects of the study eg. It should include study design, any blinding, names of comparator interventions, disease in which being tried etc.
Organization of the article would depend on the section in which it is being submitted.
Original Article
An original article is a research paper based on unique findings and techniques and provides new information on the topic. The data section should be based on information on all relevant study elements.
Appropriate statistical data is necessary for the findings to be conclusive. The Methods section should contain the criteria for the selection of human participants and laboratory animals involved in the study and provide evidence of approval from relevant ethics organizations. When human subjects are involved, the methods followed and the extent to which they were in accordance with ethical standards and Human Rights guidelines need to be indicated.
The article should include the following sections:
Abstract: Please provide Objectives, Methods and Materials, Results, and Conclusion in brief in the Abstract and do not exceed 500 words.
Please provide the following in detail in the main article: Introduction, Methods, Results, Discussion, and Conclusion (3000 words). Original articles can have references up to a maximum of 35, figures including subparts up to a maximum of 10, and Tables up to a maximum of 4.
Click here to download the Manuscript Template
Abstract
An abstract is required for all categories of manuscripts. The abstract should not exceed 500 words. The content should not have any subheadings.
For an Original Research article, the abstract should be divided into these sections:
- Background
- Aims / Objectives
- Methods
- Results
- Limitations
- Conclusion
No abstract should contain any figures, tables, references, trade names, or manufacturer’s names.
Keywords
Provide up to five keywords at the end of the abstract for all types of articles except for Letters to the Editor and Replies.
Introduction
All articles need an Introduction that describes the objective of the investigation in not more than 500 words. The author should clearly state the specific goal or purpose of the article, and indicate why it is worthy of attention. In the Introduction, describe the hypothesis to be tested, the dilemma to be resolved, or the deficiency to be remedied.
Materials and Methods or Subject Profile
It should include the study design, sample size calculation, the research question and plan, the materials (or subjects), and the methods used should be described. An explanation of how the disease was confirmed and the controls used must be included. The primary and secondary outcome measures of the study should be defined. Details of the data obtained and how it was analyzed should also be mentioned.
The name of the institution where the study was conducted should not get revealed at any place in the main text.
When a surgical device is mentioned in the manuscript for the first time, its manufacturer’s complete detail should be mentioned such as the BRAND name of the device/medication followed by name of the manufacturer, city, and state. For example IVC filter (C.R. Bard, Inc. Murray Hill, New Jersey, USA), ultrasound machine (GE, Logiq E9, Milwaukee, USA, type of transducer and its frequency).
When the study contains clinical images, details on type of camera used and its parameters should be mentioned in parenthesis.
Ethics: When reporting studies on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). For prospective studies involving human participants, authors are expected to mention about approval of (regional/national/institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for or any national law on the care and use of laboratory animals was followed.
Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors. Animal experimental procedures should be as humane as possible and the details of anaesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the “CPCSEA” and “World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans” for studies involving experimental animals and human beings, respectively. The journal will not consider any manuscript which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all original research manuscripts under the ‘Materials and Methods’ section.
Patient consent: Patient anonymity must be maintained in all submissions. If there is any possibility that the patient can be identified in a figure, written consent must be obtained from the patient or parent/guardian by the author, and a line stating that this has been received included in the article.
Study Design
Selection and Description of Participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Technical information: Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.
Reports of randomized clinical trials should present information on all major study elements, including the protocol number and date, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org).
Statistical Analysis
Whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). The authors should report losses to observation (such as dropouts from a clinical trial). When data are summarized in the Result section, specify the statistical methods used to analyze them. Avoid non-technical uses of technical terms in statistics, such as ‘random’ (which implies a randomizing device), ‘normal’, ‘significant’, ‘correlations’, and ‘sample’. Define statistical terms, abbreviations, and most symbols. Specify the computer software used. For all P values, include the exact value such as not less than 0.05 or 0.001. Mean differences in continuous variables, proportions in categorical variables and relative risks including odds ratios and hazard ratios should be accompanied by their confidence intervals.
Results
All results should be in a clear, logical sequence and should adhere to the specific objective of the paper. Data presented in tables should not be duplicated in the text. Important trends and points observed in the study will need to be described. When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Where scientifically appropriate, analyses of the data by variables such as age and sex should be included.
Discussion
The article submitted should explain clearly the outcome of the research considering the goals and results obtained. Any limitations on the materials or subjects and methods must be included. How the results differ from those obtained by previous investigators need to be presented with adequate comparisons and explanations. Include key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); Strengths and limitations of the study (study question, study design, data collection, analysis and interpretation); Interpretation and implications in the context of the totality of evidence should be described. Include what this study adds to the available evidence, effects on patient care and health policy, etc.
Do not repeat the data or other material mentioned in the Introduction or the Results section. In particular, contributors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed.
References
References are to be numbered sequentially in the order in which they appear in the manuscript. Reference numbers are typed as superscripts, after the punctuation mark at the end of the line.
Example: …… with no evidence of intratubular testicular neoplasia.1
Unpublished data or articles submitted for publication are not to be cited in the reference list. They are cited within parenthesis in the text. (Example: Aaron J, unpublished data). Papers presented at meetings are not cited in the reference list. They are cited within parenthesis in the text. (Example: Aaron J et al., presented at the 2009 annual meeting of the Society).
References follow the ICMJE guidelines. The author’s surname is followed by the author’s initials in capitals without spaces or full stops. All references show page numbers in the format (121-26). Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list from here.
Sample references are given below:
Articles in Journals
Olson MC, Posniak HV, Fisher SG, Flisak ME, Salomon CG, Flanigan RC, et al. Directed and random biopsies of the prostate: indications based on combined results of transrectal sonography and prostate-specific antigen density determinations. Am J Roentgenol 1994;163:1407–11.
Issue with supplement
Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996;23(1, Suppl 2):89-97.
Volume with supplement
Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994;102 Suppl 1:275-82.
List the first six contributors followed by et al in all references.
Books and Other Monographs
Personal Author(s):
Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.
Editor(s), compiler(s) as author:
Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.
Chapter in A Book
Turgut AT, Dogra VS. Prostate carcinoma: Evaluation using transrectal sonography. In: Hayat MA, ed. Methods of cancer diagnosis, therapy and prognosis. 1st ed. New York, NA: Elsevier; 2008. p. 499-520.
Electronic Sources as Reference
Refer APA’s Quick guide on reference for electronic references.
Monograph on the Internet format:
Foley KM, Gelband H, editors. Improving palliative care for cancer [monograph on the Internet]. Washington: National Academy Press; 2001 [cited 2002 Jul 9].
Refer Homepage/Web site and Part of a homepage/Web site formats in the hyperlink provided
Tables
Tables must be significant and provide a good summary of the study. Tables should be self-explanatory and not duplicate the data given in the text or figures. Each table must have a descriptive title, and each column a heading. Tables must contain a minimum of four lines and two columns of data and not exceed 10 columns and 25 rows. Tables are numbered in the order in which they are cited in the text. Abbreviations used in the tables are defined below each table. All arithmetic calculations (percentages, totals, differences) must be double-checked for accuracy, and data must agree with the data given in the text.
Graphs
Graphs need to be exported as JPEG or TIF images and submitted as figures. Graphs and line drawings need to be a minimum of 1000 dpi. Graphs should include clearly labeled error bars described in the figure legend. The authors must state whether a number that follows the ± sign is a standard error (SEM) or a standard deviation (SD). The number of independent data points (N) represented in a graph must be indicated in the legend. Numerical axes on graphs should go to 0, except for log axes.
Figures/Images
All images should be uploaded in high-quality JPEG, or TIF, format and the file size should be within 12 MB in size.
Figures should be numbered consecutively according to the order in which they have been cited in the text. Labels, numbers, and symbols should be clear and of uniform size. The lettering for figures should be large enough to be legible after reduction to fit the width of a printed column.
Mark the lesions in the clinical images and specific findings in the photomicrographs using arrows, arrowheads, or stars in a contrasting colour for clarity.
The clinical photographs of an individuals must be accompanied by written permission for publication and must be unidentifiable; eyes and genitalia/ breast area (if not involved in the disease process) must be masked completely.
If a figure has been published elsewhere, the source must be acknowledged and written permission from the copyright holder submitted to reproduce the material. A credit line should appear in the legend for such figures.
Electronic manipulation of images that alters medical information is unacceptable. Symbols must be uniform in size and style and large enough to withstand reduction.
Line drawings and graphs should be in black on a white background, using the same size type as the text. 0.5 mm hairline rules must be avoided. Authors’ names and affiliations must not appear anywhere on the images.
Authors should submit individual images as well as collages (when required); however, they need to ensure that each image in the collage conforms to the instructions in terms of resolution and other points mentioned above. Hence, in case of collage, authors should submit both the individual images and the final collage panel.
For collages having more than one row, label each figure alphabetically with the image on the extreme left starting as the continuation of the one on the extreme right of the upper row (for example in a panel of two rows with 4 images each, the first row images will be labelled as a,b,c,d, from left to right and second row will be e,f, g, h, from left to right).
For panels, please embed the alphabetical label within the image (For example for figure 2c embed ‘c’)
Image Size: As it is possible to alter DPI with post-processing, it is important that the image needs to be sharp and clear at an image dimension of 5-inch width.
Black and white images, JPEG, or TIF format, Grayscale mode, and have a minimum 300 DPI resolution. The height and width of an image should be at least 6 x 5 inches.
Colour images 300 DPI resolution, no layered files, no alpha channels. Colour profile if used CMYK (No Indexed Colour, Lab, or RGB profiles).
Line art: 1200 DPI resolution, Grayscale or Jpeg format. No layered files, no alpha channels. Colour profile if used: CMYK (No Indexed Colour, Lab, or RGB profiles)
The clinical images submitted including pre- and post treatment images should have uniform background, lighting and distance and must be focused. Poor quality images can lead to rejection of the paper.
The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs to an acceptable size.
Video Clips– The journal encourages authors to submit video clips, cine clips, or real-time images (preferably in ‘mp4’). The maximum size of each multimedia file should not exceed 400 MB. In addition to the video content, authors must provide a still image from each video file. Supply TIFF or JPEG files.
Figure/Image Legends – All figure parts relating to one image should have the same figure number. The style for figure legends is given here:
Figure 1: Age and gender of the patient followed by presenting symptoms and subsequent diagnosis. Imaging modality used, organ/section imaged, view, and abnormality seen in the image. Add arrows pointing to the abnormality seen in the image.
Example: Figure 1: A 42-year-old woman with Behçet disease who presented with dyspnea. (a) Contrast-enhanced CT image shows the increased diameter of both middle and lower lobe pulmonary arteries (arrows) on the right; the aneurysms are partially thrombosed. (b) CT image with lung window shows well-defined lung parenchymal nodules (arrow) corresponding to the aneurysms.
Written permission to reprint in print and electronic media, including online use, must be obtained for all previously published illustrations, and an appropriate credit line to be given in the legends.
Helpful Resources
Kaliyadan F. Image quality for publication. Indian J Dermatol Venereol Leprol. 2016 Jul-Aug;82(4):367-70.
Kaliyadan F. Image manipulation and image plagiarism – what’s fine and what’s not? Indian J Dermatol Venereol Leprol. 2017 Sep-Oct;83(5):519-521
Legends to microscopic images/photomicrographs-
This should contain detailed description of the image along with type of stain used and magnification as parenthesis. Magnification should be that of the objective lens only as x2, x4, x10, x40 etc. A photomicrograph of higher magnification should be captured at that magnification and should not be a cropped image of the image taken at lower magnification.
Any specific features being highlighted must be indicated by arrows or arrow heads of different colours which should be specified in the image legend.
Eg. Figure- Photomicrograph reveals an acanthotic epidermis composed of predominantly basaloid cells and containing multiple horn and pseudo horn cysts (yellow arrow). There is increased basal layer melanization. Papillary dermis shows many melanophages. Features are those of seborrheic keratosis (Haematoxylin and eosin stain, X10)
Epidemiological Studies
Basic Science Studies
Review Article
Award Article
Brief Reports
Commentary
Images in Dermatology
Letters to the Editor
- Study Letters (short reports of preliminary research)
- Observation Letters (interesting observations in clinical practice, short reports of I or 2 unique cases or novel treatments)
- [The manuscript should have up to 750 words, 7 references and maximum three photographs and/or Tables. There are no sub-headings within the letter. No abstract is required].
- Letters in response to previous publications
- (To be submitted in response to the Original Articles and Brief Reports only within 3 months of online publication of the article)
- Letters in reply- Reply by authors of original article/ brief report to letters from authors
Failure is instructive: mistakes made, lessons learnt
History
Residents’ page
Focus
Viewpoint
Quiz
Net Section
Net Images
Net Study
Announcements
Book Review
Supplements
Pearls/Tips and tricks
Musings
Snippets
- The title should clearly identify the manuscript as a systematic review or meta-analysis
- A structured abstract of 500 words (maximum) should be included in the submission. The components of the abstract are: Objectives, Methods and Materials, Results, and Conclusion
- The main manuscript should not exceed 5000 words. Although the number of references can be flexible, kindly include only relevant references (such as those used in the systematic review or meta-analysis, and additional important/relevant references).
- Please provide the following in detail in the main article: Introduction, Methods, Results, Discussion, Limitations, and Conclusion
- Please include a flow-chart for the inclusion/exclusion and selection of studies
- Kindly use PRISMA guidelines for reporting of systematic reviews and meta-analysis and attach the fully filled-up PRISMA checklist
- https://prisma-statement.org/prismastatement/Checklist.aspx
- If you have registered your systematic review or meta-analysis, please provide a PROSPERO number
- https://www.crd.york.ac.uk/prospero
| Article type | Word count | Abstract Limit | Keywords Limit | Introduction | Materials and Methods | Results | No of authors | References (Maximum) | Figures(Maximum) | Tables (Maximum) |
| Systematic Review | 500 words | 500 words | – | – | – | – | No limit | – | – | – |
| Original Article | 3000 words | 500 words | up to 5 | up to 500 words | – | – | No limit | up to 35 | figures including subparts up to a maximum of 10 | Up to 4 |
| Epidemiological Study | 3000 words | 500 words | up to 5 | up to 500 words | – | – | No limit | up to 35 | figures including subparts up to a maximum of 10 | Up to 4 |
| Basic Science Study | 3000 words | 500 words | up to 5 | up to 500 words | – | – | No limit | up to 35 | figures including subparts up to a maximum of 10 | Up to 4 |
| Brief Report | 1500 words | 500 words | up to 5 | up to 500 words | – | – | No limit | up to 25 | figures including subparts up to a maximum of 10 | Up to 4 |
| Meta-analysis | 5000 words | 500 words | – | – | – | – | No limit | – | – | – |
| Narrative Review | – | – | – | – | – | – | maximum of 6 authors | – | – | – |
| Letters to the Editor | 750 words | Not required | – | – | – | – | Maximum of 6 authors. Maximum of 4 authors from the primary department; 2 more authors can be added if they are not from the same department. | Up to 7 | 3 | 3 |
| Images in Dermatology | 100 words | – | – | – | – | – | Maximum of 2 authors. 3rd author can be considered in case he/she has contributed and is from a different clinical department. | No references are required | – | – |
| History | 2500 words | No abstract is required. | – | – | – | – | Maximum of 2 authors | – | – | – |
| Award Article | – | – | – | – | – | – | number of authors depends on the category of the article | – | – | – |
| Residents’ page | 1000 words | No abstract is required | – | – | – | – | Maximum of 4 authors | Up to 20 | – | – |
| Focus | 1500 words | No abstract is required | – | – | – | – | Maximum of 3 authors | – | – | – |
| Viewpoint | 500 – 1000 words | No abstract is required | – | – | – | – | Maximum of 6 authors | up to 5 | – | – |
| Quiz | 500 words | No abstract is required | – | – | – | – | Maximum of 6 authors. A maximum of 4 authors from the primary department; 2 more authors can be added if they are from the other departments e.g. radiodiagnosis and pathology department or any ancillary clinical department. | up to 5 | – | – |
| Net Section | – | – | – | – | – | – | Net Section will have the same maximum number of authors depending on the manuscript category | – | – | – |
| Announcements | 100 words | – | – | – | – | – | 1 Author | – | – | – |
| Book Review | – | – | – | – | – | – | 2 Author’s | – | – | – |
| Pearls | 500 words | – | – | – | – | – | 3 Author’s | up to 4 | 3 | – |
| Musings | – | – | – | – | – | – | 2 Author’s | – | – | – |
| Snippets | – | – | – | – | – | – | 2 Author’s | – | – | – |
Submission of the Manuscript
Online Manuscript Submission
All manuscripts must be submitted online to the Indian Journal of Dermatology, Venereology and Leprology. You will see step-by-step instructions when you are submitting your manuscript. You will need to submit the following documents as separate files.
- Cover Page:
This document should carry the title of the article, a short running title, a covering letter, the names of all contributors and their professional affiliations; the name, address, phone numbers and email address of the corresponding contributor, word count, table and figure counts, acknowledgment(s) if any and an author contribution table.
Please use the downloadable template for the same – Download Template - Manuscript:
This document should include the title, abstract, keywords, manuscript body, legends, references and tables. This must be submitted in the word document format. - Figures:
Figures must be submitted in .tiff or jpeg format. Colour images should be of good quality and a minimum of 300 dpi. The size of the image can be reduced by decreasing the actual height and width of the images (1240 x 800 pixels or 5-6 inches). IJDVL prefers individual images, and not collage. Figures are to be uploaded separately and not embedded in the main manuscript. - Graphs:
Do not embed them in the main manuscript. They should be uploaded separately at the time of uploading the figures in the “jpeg” or “tiff” format. - Tables:
Tables should be included in the main manuscript file after the references. - Copyright and disclosure forms are available for download from the author’s panel and should be uploaded as PDF files. They should be signed by all authors of the study.
- Instruction on supplemental digital multimedia/video content: In addition to the video content, authors must provide a still image from each video file. Supply TIFF or JPEG files. These are also uploaded at the time of figure upload.
Number of Authors for the Manuscript Type
- Systematic Review and Meta-analysis, Original Article, epidemiological study, basic science study and Brief Report: There is no limit on the number of authors.
- Narrative Review: A maximum of 6 authors.
- Award Article: The number of authors depends on the category of the article and should be as per the category.
- Letters to the Editor: Maximum of 6 authors. Maximum of 4 authors from the primary department; 2 more authors can be added if they are not from the same department. For example – radiodiagnosis, pathology, microbiology or any ancillary clinical department.
- Images in Dermatology: Maximum of 2 authors. 3rd author can be considered in case he/she has contributed and is from a different clinical department.
- History: Maximum of 2 authors
- Residents’ page: Maximum of 4 authors
- Focus: Maximum of 3 authors
- Viewpoint: Maximum of 3
- Quiz: Maximum of 6 authors. A maximum of 4 authors from the primary department; 2 more authors can be added if they are from the other departments e.g. radiodiagnosis and pathology department or any ancillary clinical department.
- Net Section will have the same maximum number of authors depending on the manuscript category.
- Announcements: One author
- Book Review: 2 authors
- Pearls: 3 authors
- Musings: 2 authors
- Snippets: 2 authors
Publication/Processing Fee
Article Processing Charge
The Indian Journal of Dermatology, Venereology and Leprology does not charge the authors or authors’ institutions for the submission, processing and/or publications of manuscripts.Copyright and Open Access Statement
All of the content published in the Indian Journal of Dermatology, Venereology and Leprology is protected under the International copyright law, defined by Creative Commons and International Council of Medical Journal Editors (ICMJE). The author of an article retains the academic copyright of the content and can self-archive the article. The journal retains the commercial rights of the published content and publisher executes the commercial rights on behalf of the journal. The journal also grants to all readers and users a free, irrevocable, global, perpetual right of access to, and a license to copy, use, distribute and display the content publicly and to make and distribute derivative works in any digital medium for any reasonable and non-commercial purpose, subject to proper attribution of authorship and ownership of the copyrights under the Creative Commons Attribution-Noncommercial-Share Alike 4.0 International Public License.
Click here to view sample copyright form
(Please note submission portal (EditorialAssist) will provide an option to generate the copyright form online while submitting the manuscript)
Open Access Publication and Creative Commons Licensing
Indian Journal of Dermatology, Venereology and Leprology is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0), which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Compliance with Funder-Mandated Open Access Policies
An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 License is able to meet that requirement through the available open-access license for approved funders.
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party. For any Questions or Difficulties please contact us technical.team@scientificscholar.com